<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>次新股研究 | wechat-feeds</title><link>http://MzIxMjIxNDYwNA.favicon.privacyhide.com/favicon.ico</link><description>在这里读懂次新，挖掘十倍大牛股！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 13 Jun 2021 21:28:42 +0800</pubDate><image><url>http://MzIxMjIxNDYwNA.favicon.privacyhide.com/favicon.ico</url><title>次新股研究 | wechat-feeds</title><link>http://MzIxMjIxNDYwNA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>投资13亿的《长津湖》，票房能否打破记录？市场存在那些投资机会？</title><link>https://mp.weixin.qq.com/s/FdnDf8rRm3mi31bNgzdA4w</link><description></description><content:encoded><![CDATA[投资13亿的《长津湖》，票房能否打破记录？市场存在那些投资机会？]]></content:encoded><pubDate>Sun, 13 Jun 2021 19:09:21 +0800</pubDate></item><item><title>华为智能汽车产业研究与投资机会分析</title><link>https://mp.weixin.qq.com/s/r9XqVEXfbu_EnEX86Ps2Hg</link><description></description><content:encoded><![CDATA[华为智能汽车产业研究与投资机会分析]]></content:encoded><pubDate>Sat, 12 Jun 2021 08:00:59 +0800</pubDate></item><item><title>次新股复盘：多空对战</title><link>https://mp.weixin.qq.com/s/HaSXgKD7I7Bd2Bt7lmse3w</link><description></description><content:encoded><![CDATA[次新股复盘：多空对战]]></content:encoded><pubDate>Wed, 09 Jun 2021 15:21:47 +0800</pubDate></item><item><title>次新股复盘：指数高位震荡你们说何去何从？</title><link>https://mp.weixin.qq.com/s/rppBb-81kdqSLJAVGbdidA</link><description></description><content:encoded><![CDATA[次新股复盘：指数高位震荡你们说何去何从？]]></content:encoded><pubDate>Tue, 08 Jun 2021 15:20:22 +0800</pubDate></item><item><title>次新股复盘：指数高位震荡后续何去何从？</title><link>https://mp.weixin.qq.com/s/kf5CE5ryFFLizhbT8dOn4g</link><description></description><content:encoded><![CDATA[次新股复盘：指数高位震荡后续何去何从？]]></content:encoded><pubDate>Sun, 06 Jun 2021 20:32:46 +0800</pubDate></item><item><title>次新股研究——皓元医药688131：深耕小分子药物领域 致力成为世界一流医药研发和生产服务企业</title><link>https://mp.weixin.qq.com/s/T4pQfPvSr6B4RPmZv6JiSg</link><description></description><content:encoded><![CDATA[次新股研究——皓元医药688131：深耕小分子药物领域 致力成为世界一流医药研发和生产服务企业]]></content:encoded><pubDate>Sat, 05 Jun 2021 21:33:14 +0800</pubDate></item><item><title>为中华数风流 还看今朝是鸿蒙（市场有哪些投资标的？）</title><link>https://mp.weixin.qq.com/s/AJNh2c-_6pYzIHJeCr-n2A</link><description></description><content:encoded><![CDATA[为中华数风流 还看今朝是鸿蒙（市场有哪些投资标的？）]]></content:encoded><pubDate>Thu, 03 Jun 2021 23:31:05 +0800</pubDate></item><item><title>次新股复盘：市场高潮之后呢？</title><link>https://mp.weixin.qq.com/s/b1FMK4CL9lIFjazsQV6-Pw</link><description></description><content:encoded><![CDATA[次新股复盘：市场高潮之后呢？]]></content:encoded><pubDate>Wed, 02 Jun 2021 16:54:13 +0800</pubDate></item><item><title>丽芙莎高C针，能否让A股G潮呢？</title><link>https://mp.weixin.qq.com/s/lgbTU-M4s-dh_Xbx21BABg</link><description></description><content:encoded><![CDATA[丽芙莎高C针，能否让A股G潮呢？]]></content:encoded><pubDate>Sun, 30 May 2021 23:43:45 +0800</pubDate></item></channel></rss>